Hematology Consults

Pancytopenia

Confirm the cytopenias, determine whether production is impaired or cells are being destroyed or sequestered, recognize smear emergencies, identify reversible causes, and decide when bone marrow evaluation is required.

Audience: internal medicine residents Last reviewed: July 2026

Bedside approach

Answer these questions first

Is pancytopenia real? Repeat the CBC, review analyzer flags, inspect the smear, and compare with previous counts.
Is the patient unstable? Assess fever, sepsis, active bleeding, symptomatic anemia, neurologic findings, and hemodynamics.
Is marrow production impaired? A low absolute reticulocyte response supports reduced production, although mixed mechanisms are common.
What does the smear show? Blasts, promyelocytes, schistocytes, teardrops, nucleated RBCs, or marked dysplasia may immediately change the pathway.
Is there splenomegaly? Splenic sequestration may contribute, but marked or progressive pancytopenia should not automatically be attributed to the spleen.
Is there a reversible exposure? Review medications, chemotherapy, alcohol, infection, nutrition, radiation, toxins, and supplements.

Urgent escalation

  • Fever or sepsis with severe neutropenia
  • Major, critical-site, or hemodynamically significant bleeding
  • Symptomatic anemia, ischemia, syncope, or rapid hemoglobin decline
  • Blasts or suspected acute leukemia
  • Abnormal promyelocytes with bleeding, prolonged coagulation studies, low fibrinogen, or concern for acute promyelocytic leukemia
  • Schistocytes with thrombocytopenia and biochemical hemolysis
  • Severe pancytopenia with a markedly hypocellular marrow syndrome
  • Persistent fever, organomegaly, liver injury, cytopenias, and rapidly increasing ferritin suggesting HLH
Possible acute promyelocytic leukemia is an emergency. Contact hematology immediately and follow the institution’s APL/DIC pathway rather than waiting for routine outpatient confirmation.

1. Confirm the pattern and obtain the initial workup

  1. Repeat the CBC with differential and calculate the absolute neutrophil count.
  2. Review the peripheral smear for blasts, dysplasia, schistocytes, teardrops, nucleated RBCs, hypersegmented neutrophils, parasites, platelet clumping, and giant platelets.
  3. Obtain an absolute reticulocyte count and interpret it against the severity of anemia.
  4. Review prior CBCs to determine whether the process is acute, progressive, fluctuating, or longstanding.
  5. Review medications, recent chemotherapy or radiation, alcohol, supplements, infections, travel, nutritional intake, and systemic symptoms.

Common initial laboratory tests

Core tests

  • Repeat CBC with differential
  • Absolute neutrophil count
  • Absolute reticulocyte count
  • Peripheral smear
  • Creatinine and electrolytes
  • AST, ALT, bilirubin, alkaline phosphatase, albumin
  • LDH and haptoglobin when hemolysis is possible
  • PT/INR, aPTT, fibrinogen, and D-dimer when DIC is possible

Cause-directed tests

  • Vitamin B12 and folate
  • Iron studies
  • Copper and zinc when clinically appropriate
  • HIV and hepatitis testing
  • EBV, CMV, parvovirus, or tick-borne testing when indicated
  • Ferritin, triglycerides, and fibrinogen when HLH is possible
  • PNH flow cytometry when marrow failure or hemolysis suggests it
  • Pregnancy testing when relevant

2. Pattern recognition

Pattern Important causes Clues and next steps
Low reticulocyte response Aplastic anemia, leukemia, MDS, marrow infiltration, chemotherapy, medication toxicity, infection, nutritional deficiency, severe inflammation Review smear, exposures, nutrient studies, viral testing, and proceed to marrow evaluation when unexplained.
Macrocytosis Vitamin B12 or folate deficiency, alcohol, liver disease, medications, MDS, hypothyroidism, reticulocytosis Check B12, folate, smear morphology, liver studies, medications, and marrow features when persistent.
Blasts Acute leukemia or another aggressive marrow neoplasm Urgent hematology evaluation, flow cytometry, coagulation studies, tumor-lysis assessment, and marrow testing.
Leukoerythroblastic smear Marrow infiltration, myelofibrosis, metastatic cancer, severe marrow stress Look for nucleated RBCs, immature myeloid cells, teardrops, organomegaly, and imaging findings.
Schistocytes TMA, DIC, mechanical destruction Review platelets, hemolysis markers, coagulation studies, creatinine, neurologic findings, and blood pressure.
Splenomegaly Portal hypertension, liver disease, infection, lymphoma, myeloproliferative disease, infiltrative disorders Review liver disease, imaging, lymphadenopathy, constitutional symptoms, and marrow findings.
Fever and very high ferritin Infection, liver injury, malignancy, inflammatory disease, HLH Ferritin is not specific. Review trajectory, cytopenias, organomegaly, triglycerides, fibrinogen, liver injury, and the overall syndrome.

3. Differential diagnosis by mechanism

Reduced marrow production

  • Acute leukemia
  • Myelodysplastic neoplasm
  • Aplastic anemia
  • Myelofibrosis
  • Metastatic or lymphomatous marrow infiltration
  • Chemotherapy or radiation
  • Medication or toxin effect
  • Severe B12, folate, or copper deficiency
  • Viral marrow suppression
  • Severe systemic inflammation

Destruction, consumption, or sequestration

  • DIC
  • TTP or another TMA
  • Autoimmune cytopenias
  • HLH
  • Hypersplenism
  • Severe infection or sepsis
  • Hemorrhage with dilution or consumption
  • Immune medication reactions
  • Pregnancy-related microangiopathy

Medication and exposure review

Determine when each exposure began and whether the mechanism is marrow suppression, immune destruction, nutritional interference, TMA, or direct toxicity. Relevant exposures include chemotherapy, radiation, linezolid, trimethoprim-sulfamethoxazole, antiepileptics, antithyroid drugs, immunosuppressants, alcohol, benzene, and other marrow-toxic agents.

Interactive tools

Reticulocyte response

Corrected reticulocyte percentage

Enter the reticulocyte percentage and hematocrit.

Corrected retic = retic % × patient hematocrit ÷ reference hematocrit.

Reticulocyte production index

Enter the reticulocyte percentage and hematocrit.

RPI = corrected reticulocyte percentage ÷ maturation factor.

A low reticulocyte response supports impaired production, but it does not identify the cause. Severe infection, renal dysfunction, nutrient deficiency, and marrow disease can coexist with peripheral destruction.

4. When to perform bone marrow evaluation

Bone marrow aspirate and biopsy are generally appropriate when pancytopenia remains unexplained after the initial clinical and laboratory evaluation or when the smear and clinical course suggest a primary marrow disorder. [2] [3]

Strong indications

  • Blasts or marked dysplasia
  • Leukoerythroblastic smear or teardrop cells
  • Persistent or progressive unexplained pancytopenia
  • Severe hypocellular marrow-failure phenotype
  • Concern for leukemia, MDS, aplastic anemia, myelofibrosis, or infiltration
  • Unexplained constitutional symptoms, lymphadenopathy, or organomegaly
  • Failure of counts to recover after an expected transient insult

Common marrow studies

  • Aspirate morphology
  • Core-biopsy cellularity and architecture
  • Flow cytometry
  • Cytogenetics and FISH
  • Myeloid or disease-specific molecular testing
  • Iron stain and selected infectious stains or cultures
Bone marrow hemophagocytosis is neither required nor specific for HLH. It may be absent early and may occur in infection, transfusion, critical illness, and other inflammatory states.

Interactive tool

HScore for reactive hemophagocytic syndrome

Use the HScore when the clinical syndrome raises concern for secondary HLH. It is not a screening test for every patient with pancytopenia or an isolated elevated ferritin. [4] [5]

Original HScore thresholds: hemoglobin ≤9.2 g/dL, WBC ≤5.0 × 10⁹/L, and platelets ≤110 × 10⁹/L.

Select the findings above.

The probability is estimated from the original HScore logistic model. Results depend strongly on pretest probability and should not delay hematology consultation or treatment of a critically ill patient with a convincing HLH syndrome.

Adult HLH often presents with persistent fever, cytopenias, hepatosplenomegaly, liver injury, coagulation abnormalities, and substantial hyperferritinemia. Ferritin alone is not specific, even when markedly elevated. [5] [6]

5. Supportive care while evaluating the cause

Neutropenia

  • Calculate the ANC rather than relying only on the total WBC count.
  • Fever with severe neutropenia requires prompt institutional febrile-neutropenia management.
  • Obtain cultures and begin empiric antimicrobial therapy according to the local pathway when indicated.
  • Do not delay treatment while completing the pancytopenia workup.

Red-cell transfusion

Use symptoms, hemodynamics, active bleeding, cardiovascular disease, ischemia, and the rate of decline rather than a single universal hemoglobin number. Restrictive transfusion strategies are appropriate for many stable hospitalized adults, but important exceptions require individualized management. [7]

Platelet transfusion

Platelet thresholds depend on bleeding status, mechanism, procedures, and clinical setting. Use the current institutional policy and the dedicated thrombocytopenia guide rather than applying one target to every patient. [8]

Avoid routine growth-factor, steroid, immunoglobulin, or transfusion treatment until the likely mechanism and clinical indication are understood—unless an emergency requires immediate supportive care.

6. Resident summary

  1. Confirm all three cytopenias and compare with previous counts.
  2. Inspect the smear before assigning a benign explanation.
  3. Use the reticulocyte response to separate impaired production from regenerative processes.
  4. Check reversible causes including medications, infection, alcohol, B12, folate, copper, liver disease, and splenic sequestration.
  5. Blasts, promyelocytes, schistocytes, teardrops, and a leukoerythroblastic picture require urgent escalation.
  6. Persistent unexplained pancytopenia commonly requires bone marrow aspirate and biopsy.
  7. Use HScore only when the broader syndrome raises concern for HLH.
  8. Treat fever with severe neutropenia and clinically important bleeding or anemia without waiting for the entire diagnostic evaluation.

7. Knowledge check

Question 1

A patient has pancytopenia, an absolute reticulocyte count that is very low, and no evidence of hemolysis or bleeding. Which mechanism is most likely?

Question 2

A patient with pancytopenia has circulating blasts and new gingival bleeding. What is the priority?

Question 3

Which finding most strongly supports proceeding to bone marrow evaluation?

Question 4

A patient has ferritin 9,000 ng/mL. Which statement is most accurate?

Question 5

A patient has fever, ANC 200/µL, hypotension, and pancytopenia. What should happen first?

References

  1. Chew S, et al. Approach to pancytopenia: From blood tests to the bedside. Clinical Medicine. 2024. Open article
  2. DeZern AE, Churpek JE. Approach to the diagnosis of aplastic anemia. Blood Advances. 2021. Open article
  3. Garcia-Manero G, et al. Diagnosis and classification of myelodysplastic syndromes. Blood. 2023. Open article
  4. Fardet L, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis & Rheumatology. 2014. PubMed
  5. La Rosée P, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019. Open article
  6. Schram AM, et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood. 2015. Open article
  7. Carson JL, et al. Red blood cell transfusion: 2023 AABB international guidelines. AABB summary
  8. AABB and ICTMG. Platelet transfusion international clinical practice guidelines. 2025. AABB summary

Educational disclaimer

This guide is intended for clinician education and does not replace institutional protocols, hematology consultation, transfusion-service guidance, infectious-disease input, or individualized clinical judgment. Febrile neutropenia, suspected acute leukemia, severe marrow failure, major bleeding, and possible HLH require urgent local escalation.